107 results
8-K
EX-99.1
EVH
Evolent Health Inc - Ordinary Shares
22 Feb 24
Evolent Announces Fourth Quarter and Full Year 2023 Results
4:18pm
from operations of $142.6 million
Provides initial outlook for 2024 in line with long-term targets
WASHINGTON (February 22, 2024) – Evolent Health … /repayment on long-term debt, net
Change in tax receivables agreement liability
Other income (expense), net
Loss before income taxes
Provision
8-K
EX-99.1
EVH
Evolent Health Inc - Ordinary Shares
8 Jan 24
Results of Operations and Financial Condition
5:00pm
Business Model Target Mature Flow-Through Margins Avg PMPM Fees/Revenue1 Potential Long-Term Growth Recurring Capitation; Targeted Results “Risk-Based … outlook 2024 Adjusted EBITDA target and long-term growth rates 2023 revenue range of $1.945 billion - $1.965 billion; 2023 Adjusted EBITDA1, 2 $192
8-K
EX-10.1
g1v47kfikteqkzftevax
8 Dec 23
Entry into a Material Definitive Agreement
6:16pm
8-K
EX-99.1
40ay217gw8lzc8r ud
2 Nov 23
Combined Financial Statements
8:09pm
8-K
EX-99.2
8x6eutqsv8yrsaqbw
2 Nov 23
Combined Financial Statements
8:09pm
8-K
EX-99.1
tsdtbij
2 Nov 23
Evolent Announces Third Quarter 2023 Results
4:18pm
8-K/A
EX-99.1
k00o4r3u9gcwm
13 Oct 23
Combined Unaudited Financial Statements
5:35pm
8-K/A
EX-99.2
jsoon kjd8wz5nkacp9
13 Oct 23
Combined Unaudited Financial Statements
5:35pm
8-K/A
EX-99.3
jaou5
26 Sep 23
Combined Financial Statements
5:28pm
8-K/A
EX-99.1
5gsua6 9v6b0h1pa
26 Sep 23
Combined Financial Statements
5:28pm
8-K
EX-99.1
gjvhagzu
2 Aug 23
Evolent Announces Second Quarter 2023 Results
4:16pm
8-K
EX-99.1
lozbss3goe1v0
3 May 23
Evolent Health Announces First Quarter 2023 Results
4:15pm
8-K
EX-99.2
xvh8a
17 Nov 22
Entry into a Material Definitive Agreement
4:04pm